Novartis Announces Russian Regulatory Approval For Gilenya®, A Once-daily Oral Multiple Sclerosis Therapy And First In A New Class
Links shared publicly online about this topic.
- 879total visits
Novartis Announces Russian Regulatory Approval For Gilenya®, A Once-daily Oral Multiple Sclerosis Therapy And First In A New Class
View full resource at medicalnewstoday.com
Tags: Multiple Sclerosis, Healthcare, Novartis
Most Recently Shared on September 17, 2010 at 6:01 pm By:
MedNewsToday: Novartis Announces Russian Regulatory Approval For Gilenya®, A Once-daily Oral Multiple Sclerosis Th... http://mnt.to/f/3JCZ
Also Shared By:
First Oral Treatment For People With Multiple Sclerosis Approved In Canada
medicalnewstoday.com — “Novartis Pharmaceuticals Canada Inc. announced that its new MS treatment, Gilenya™ (fingolimod), has received Notice of Compliance in Canada. Gilenya™ (fingolimod) is the first disease” View full resource at medicalnewstoday.com
Most Recently Shared on March 11, 2011 at 10:05 am By:
First Oral Treatment For People With Multiple Sclerosis Approved In Canada http://mnt.to/3S92 #multiplesclerosis
Pharmacy Europe - Novartis announces Russian regulatory approval for Gilenya
pharmacyeurope.net — “Pharmacy Europe, daily news for pharmacists, hundreds of clinical and best practice articles, online comment and video presentations.” View full resource at pharmacyeurope.net
Most Recently Shared on September 11, 2010 at 8:16 am By:
Drugs and Devices OW OW Health
Novartis announces Russian regulatory approval for Gilenya: Russia is first country to approve Gilenya for the tre... http://bit.ly/d5XxRk
Advertisement
MNT Multiple Scl
@mnt_multiplescl
First Oral Treatment For People With Multiple Sclerosis Approved In Canada http://mnt.to/3S92 #multiplesclerosis
1 year ago...